Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 6/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17338126 | 1.00 | MAPT (0.54) | MAPTMEN1KMT2AATML3MBTL1 | |
| SCHEMBL15261467 | 1.00 | MAPT (0.54) | MAPTMEN1KMT2AATML3MBTL1 | |
| SCHEMBL15261386 | 1.00 | MAPT (0.54) | MAPTMEN1KMT2AATML3MBTL1 | |
| SCHEMBL15262342 | 1.00 | MAPT (0.54) | MAPTMEN1KMT2AATML3MBTL1 | |
| SCHEMBL16755279 | 0.93 | MAPT (0.49) | MAPTMEN1KMT2AATML3MBTL1 | |
| SCHEMBL14637305 | 0.93 | MAPT (0.49) | MAPTMEN1KMT2AATML3MBTL1 | |
| SCHEMBL7546145 | 0.84 | MEN1 (0.56) | MAPTMEN1KMT2AATML3MBTL1 | |
| SCHEMBL2951661 | 0.81 | TSHR (0.36) | MAPTMEN1KMT2AATML3MBTL1 | |
| SCHEMBL357426 | 0.81 | MEN1 (0.56) | MAPTMEN1KMT2AATML3MBTL1 | |
| SCHEMBL15261387 | 0.81 | MAPT (0.39) | MAPTMEN1KMT2AATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024030568-A1 | SKIN AND HAIR CARE FORMULATIONS | Clarity Cosmetics Inc. (US) | 2024-02-08 | — | — | WO | claimed |
| WO-2023180932-A1 | AGRICULTURAL COMPOSITION | ORO AGRI EUROPE, S.A. (PT) | 2023-09-28 | — | — | WO | claimed |
| US-11589581-B2 | Disinfectant formulation | LABORATOIRE M2 (CA) | 2023-02-28 | — | — | US | claimed |
| WO-2022150142-A2 | RE-ATTACHABLE SOLID-PHASE ADHESIVE AND DEVICES | SIEVERDING DAVID (US) | 2022-07-14 | — | — | WO | claimed |
| US-20220186090-A1 | REATTACHABLE ADHESIVE PRODUCTS | SIEVERDING DAVID (US) | 2022-06-16 | — | — | US | claimed |
| CN-114366682-A | Pet shampoo capable of expelling parasites, removing odor and inhibiting bacteria | 广州市浪奇实业股份有限公司 | 2022-04-19 | — | — | CN | claimed |
| EP-3919459-A1 | COMPOSITION FOR AERATED OR LIGHTWEIGHT CONCRETE | Coatex (FR) | 2021-12-08 | — | — | EP | claimed |
| WO-2021234461-A1 | COMPOSITION FOR AERATED OR LIGHTWEIGHT CONCRETE | COATEX (FR) | 2021-11-25 | — | — | WO | claimed |
| US-20210275405-A1 | Hygiene Product Pod and Methods of Using Same | CMC Group, Inc. | 2021-09-09 | — | — | US | claimed |
| US-11045397-B2 | Hygiene product pod and methods of using same | Nohbo, LLC (US) | 2021-06-29 | — | — | US | claimed |
| EP-2277860-A1 | Compositions comprising sulfonated estolides and alkyl ester sulfonates, methods of making them, and compositions and processes employing them | STEPAN COMPANY (US) | 2011-01-26 | — | — | EP | claimed |
| EP-2270122-A2 | Sulfonated estolides and other derivatives of fatty acids, methods of making them, and compositions and processes employing them | STEPAN COMPANY (US) | 2011-01-05 | — | — | EP | claimed |
| EP-2249653-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | Taylor Fresh Foods, Inc (US) | 2010-11-17 | — | — | EP | claimed |
| EP-2247574-A2 | SULFONATED ESTOLIDES AND OTHER DERIVATIVES OF FATTY ACIDS, METHODS OF MAKING THEM, AND COMPOSITIONS AND PROCESSES EMPLOYING THEM | STEPAN COMPANY (US) | 2010-11-10 | — | — | EP | claimed |
| US-7666828-B2 | Sulfonated estolides and other derivatives of fatty acids, methods of making them, and compositions and processes employing them | STEPAN COMPANY (US) | 2010-02-23 | — | — | US | claimed |
| US-20100017969-A1 | Sulfonated Estolide Compositions Containing Magnesium Sulfate and Processes Employing Them | STEPAN COMPANY | 2010-01-28 | — | — | US | claimed |
| US-20100016198-A1 | Compositions Comprising Sulfonated Estolides And Alkyl Ester Sulfonates, Methods Of Making Them, And Compositions And Processes Employing Them | STEPAN COMPANY | 2010-01-21 | — | — | US | claimed |
| WO-2009099419-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | TAYLOR FRESH FOODS, INC (US) | 2009-08-13 | — | — | WO | claimed |
| WO-2009094336-A2 | SULFONATED ESTOLIDES AND OTHER DERIVATIVES OF FATTY ACIDS, METHODS OF MAKING THEM, AND COMPOSITIONS AND PROCESSES EMPLOYING THEM | STEPAN COMPANY (US) | 2009-07-30 | — | — | WO | claimed |
| US-20090188055-A1 | SULFONATED ESTOLIDES AND OTHER DERIVATIVES OF FATTY ACIDS, METHODS OF MAKING THEM, AND COMPOSITIONS AND PROCESSES EMPLOYING THEM | STEPAN COMPANY (US) | 2009-07-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090188055-A1 | SULFONATED ESTOLIDES AND OTHER DERIVATIVES OF FATTY ACIDS, METHODS OF MAKING THEM, AND COMPOSITIONS AND PROCESSES EMPLOYING THEM | STS, ABHD16A, HDHD5 | MAPT 4781/4885MEN1 4802/4885KMT2A 1671/4885 |
| US-20100016198-A1 | Compositions Comprising Sulfonated Estolides And Alkyl Ester Sulfonates, Methods Of Making Them, And Compositions And Processes Employing Them | STS, ABHD16A, DEGS1 | MAPT 4083/4885MEN1 3952/4885KMT2A 1903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.